3tophthalmics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | 3TOPHTHALMICS |
| Description | Targeting better and less invasive therapies to restore Targeting better and less invasive therapies to restore vision Home Research Clinical Trials About us --> --> INNOVATIVE, less invasive ocular DRUG |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 98.137.244.30 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
3tophthalmics.com Valuation
|
US$1,822,389
Last updated: 2023-05-10 23:36:23
3tophthalmics.com has Semrush global rank of 5,807,930. 3tophthalmics.com has an estimated worth of US$ 1,822,389, based on its estimated Ads revenue. 3tophthalmics.com receives approximately 210,276 unique visitors each day. Its web server is located in United States, with IP address 98.137.244.30. According to SiteAdvisor, 3tophthalmics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,822,389 |
| Daily Ads Revenue | US$1,683 |
| Monthly Ads Revenue | US$50,467 |
| Yearly Ads Revenue | US$605,594 |
| Daily Unique Visitors | 14,019 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| 3tophthalmics.com. | A | 1200 | IP: 98.137.244.30 |
| 3tophthalmics.com. | NS | 86400 | NS Record: yns2.yahoo.com. |
| 3tophthalmics.com. | NS | 86400 | NS Record: yns1.yahoo.com. |
| 3tophthalmics.com. | MX | 1200 | MX Record: 10 mx-biz.mail.am0.yahoodns.net. |
| 3tophthalmics.com. | TXT | 1200 | TXT Record: i=321&m=geo-g6-mx2-p10 |
HtmlToTextCheckTime:2023-05-10 23:36:23
| Targeting better and less invasive therapies to restore vision Home Research Clinical Trials About us --> --> INNOVATIVE, less invasive ocular DRUG DELIVERY With no need to penetrate the eye, 3T’s proprietary technology can deliver a number of therapeutic agents to treat neoplastic, inflammatory, neovascular and neurodegenerative ocular diseases. --> Targeted Therapy Technologies, LLC (3T Ophthalmics) Receives FDA Breakthrough Therapy Designation for Episcleral Topotecan for the Treatment of Retinoblastoma—a Pediatric Ocular Cancer Irvine, California, 4th October 2021 Targeted Therapy Technologies, LLC (3T Ophthalmics) has been awarded Breakthrough Therapy Designation by the U.S. Food and Drug Administration for its lead anti-cancer drug product candidate, Episcleral Topotecan, for the treatment of pediatric Retinoblastoma. Breakthrough Therapy Designation requires that the drug candidate treat a serious or life-threatening disease or condition. It also requires preliminary |
HTTP Headers
HTTP/1.1 200 OK Date: Wed, 03 Nov 2021 16:06:50 GMT P3P: policyref="https://policies.yahoo.com/w3c/p3p.xml", CP="CAO DSP COR CUR ADM DEV TAI PSA PSD IVAi IVDi CONi TELo OTPi OUR DELi SAMi OTRi UNRi PUBi IND PHY ONL UNI PUR FIN COM NAV INT DEM CNT STA POL HEA PRE LOC GOV" X-Host: p10w23.geo.gq1.yahoo.com X-INKT-URI: http://www.3tophthalmics.com//index.html X-INKT-SITE: http://www.3tophthalmics.com Last-Modified: Thu, 07 Oct 2021 03:22:53 GMT Accept-Ranges: bytes Content-Length: 148782 Vary: Accept-Encoding Content-Type: text/html Age: 0 Connection: keep-alive Server: ATS |
3tophthalmics.com Whois Information
Domain Name: 3TOPHTHALMICS.COM Registry Domain ID: 211134318_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-08-19T04:59:35Z Creation Date: 2005-09-17T17:24:09Z Registry Expiry Date: 2022-09-17T17:24:09Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: YNS1.YAHOO.COM Name Server: YNS2.YAHOO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-09T07:34:18Z <<< |